FindTrial
Sign In

Comparative study of various confirmatory tests used in drug reactions.

Comparative study of sensitivity of various tests used to detect adverse cutaneous drug reactions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/015023
Enrollment
50
Registered
2018-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Stable patients

Interventions

Intervention1: Prick test,intradermal test,oral rechallenge test: Serial dilution of suspected drugs for prick and intradermal test.One tenth dose of suspected drug for oral rechallenge.It will be don

Sponsors

IMS BHU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All cases of adverse cutaneous drug reactions. Prick test and Intradermal test and Oral Rechallenge test will be performed.

Exclusion criteria

Exclusion criteria: For oral rechallenge test TEN and SJS.

Design outcomes

Primary

MeasureTime frame
Positive Or Negetive intradermal testTimepoint: For skin prick test 20 minutes and 24 hours, for intradermal test 1 week, for oral challenge test till 2 weeks.—

Secondary

MeasureTime frame
Experience of the main primary outcomeTimepoint: 7 days—

Countries

India

Contacts

Public ContactSatyendra Kumar Singh

Institute of Medical Sciences

drsatyendraderma@gmail.com9198120582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026